{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T14:13:42Z","timestamp":1786889622094,"version":"build-2736575974"},"reference-count":111,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Multiple myeloma is a hematologic malignancy characterized by the clonal proliferation of plasma cells within the bone marrow. The tumor microenvironment plays a crucial role in multiple myeloma pathogenesis, progression, and drug resistance. Traditional two-dimensional cell culture models have been instrumental in multiple myeloma research. However, they fail to recapitulate the complex in vivo bone marrow microenvironment, leading to limited predictive value for clinical outcomes. Three-dimensional cell culture models emerged as more physiologically relevant systems, offering enhanced insights into multiple myeloma biology. Scaffold-based systems (e.g., hydrogels, collagen, and Matrigel), scaffold-free spheroids, and bioprinted models have been developed to simulate the bone marrow microenvironment, incorporating key components like mesenchymal stromal cells, osteoblasts, endothelial cells, and immune cells. These models enable the functional assessment of cell adhesion-mediated drug resistance, cytokine signaling networks, and hypoxia-induced adaptations, which are often lost in 2D cultures. Moreover, 3D platforms demonstrated improved predictive value in preclinical drug screening, facilitating the evaluation of novel agents and combination therapies in a setting that better mimics the in vivo tumor context. Hence, 3D cultures represent a pivotal step toward bridging the gap between basic myeloma research and translational applications, supporting the development of more effective and patient-specific therapies.<\/jats:p>","DOI":"10.3390\/ijms26136229","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:28:28Z","timestamp":1751347708000},"page":"6229","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Modeling the Bone Marrow Niche in Multiple Myeloma: From 2D Cultures to 3D Systems"],"prefix":"10.3390","volume":"26","author":[{"given":"Adele","family":"Bottaro","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elisa","family":"Nasso","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7947-158X","authenticated-orcid":false,"given":"Fabio","family":"Stagno","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8804-2640","authenticated-orcid":false,"given":"Manlio","family":"Fazio","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-8239","authenticated-orcid":false,"given":"Alessandro","family":"Allegra","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","first-page":"229","article-title":"Establishment of A Three-Dimensional Culture Condition for The U266 Cell Line Based on Peripheral Blood Plasma-Derived Fibrin Gels","volume":"25","author":"Jomehpour","year":"2023","journal-title":"Cell J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biomaterials.2015.09.017","article-title":"3D Tissue-Engineered Bone Marrow as a Novel Model to Study Pathophysiology and Drug Resistance in Multiple Myeloma","volume":"73","author":"Muz","year":"2015","journal-title":"Biomaterials"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.20517\/cdr.2022.23","article-title":"Therapeutics to Harness the Immune Microenvironment in Multiple Myeloma","volume":"5","author":"Driscoll","year":"2022","journal-title":"Cancer Drug Resist."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood-2008-02-142430","article-title":"A Unique Three-Dimensional Model for Evaluating the Impact of Therapy on Multiple Myeloma","volume":"112","author":"Kirshner","year":"2008","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.yexcr.2017.09.012","article-title":"SAHA-Induced TRAIL-Sensitisation of Multiple Myeloma Cells Is Enhanced in 3D Cell Culture","volume":"360","author":"Arhoma","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-pathol-011110-130249","article-title":"Pathogenesis of Myeloma","volume":"6","author":"Anderson","year":"2011","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1200\/JCO.20.00437","article-title":"Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression","volume":"38","author":"Bustoros","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The Genetic Architecture of Multiple Myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"102284","DOI":"10.1016\/j.ctrv.2021.102284","article-title":"Roadmap to Cure Multiple Myeloma","volume":"100","author":"Paiva","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2141.2003.04282.x","article-title":"Hyaluronan, a Major Non-protein Glycosaminoglycan Component of the Extracellular Matrix in Human Bone Marrow, Mediates Dexamethasone Resistance in Multiple Myeloma","volume":"121","author":"Vincent","year":"2003","journal-title":"Br. J. Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2186494","DOI":"10.1155\/2019\/2186494","article-title":"Immunotherapeutics in Multiple Myeloma: How Can Translational Mouse Models Help?","volume":"2019","author":"Cooke","year":"2019","journal-title":"J. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kantaros, A., and Ganetsos, T. (2023). From Static to Dynamic: Smart Materials Pioneering Additive Manufacturing in Regenerative Medicine. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115748"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kantaros, A. (2022). 3D Printing in Regenerative Medicine: Technologies and Resources Utilized. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232314621"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Yaneva, A., Shopova, D., Bakova, D., Mihaylova, A., Kasnakova, P., Hristozova, M., and Semerdjieva, M. (2023). The Progress in Bioprinting and Its Potential Impact on Health-Related Quality of Life. Bioengineering, 10.","DOI":"10.3390\/bioengineering10080910"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/028418600750063488","article-title":"Homing of the Myeloma Cell Clone","volume":"39","author":"Vanderkerken","year":"2000","journal-title":"Acta Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1034\/j.1600-065X.2003.00035.x","article-title":"Multiple Myeloma Biology: Lessons from the 5TMM Models","volume":"194","author":"Vanderkerken","year":"2003","journal-title":"Immunol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1172\/JCI77181","article-title":"Immunosurveillance and Therapy of Multiple Myeloma Are CD226 Dependent","volume":"125","author":"Guillerey","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"21777","DOI":"10.18632\/oncotarget.4970","article-title":"Thymic Involution beyond T-Cell Insufficiency","volume":"6","author":"Coder","year":"2015","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.immuni.2012.02.006","article-title":"Maintenance of Peripheral Naive T Cells Is Sustained by Thymus Output in Mice but Not Humans","volume":"36","author":"Mugwagwa","year":"2012","journal-title":"Immunity"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood-2012-08-448548","article-title":"Tumor-Promoting Immune-Suppressive Myeloid-Derived Suppressor Cells in the Multiple Myeloma Microenvironment in Humans","volume":"121","author":"Whitehill","year":"2013","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"S\u00f8rrig, R., Klausen, T.W., Salomo, M., Vangsted, A.J., Fr\u00f8lund, U.C., Andersen, K.T., Klostergaard, A., Helleberg, C., Pedersen, R.S., and Pedersen, P.T. (2017). Immunoparesis in Newly Diagnosed Multiple Myeloma Patients: Effects on Overall Survival and Progression Free Survival in the Danish Population. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188988"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2141.2007.06705.x","article-title":"Immunodeficiency and Immunotherapy in Multiple Myeloma","volume":"138","author":"Pratt","year":"2007","journal-title":"Br. J. Haematol."},{"key":"ref_26","first-page":"452","article-title":"The role of T-cell dysfunction in the pathogenesis and treatment of multiple myeloma","volume":"24","author":"Minnema","year":"2010","journal-title":"Leukemia"},{"key":"ref_27","first-page":"385","article-title":"Therapeutic strategies targeting immune dysfunction in multiple myeloma","volume":"169","author":"Dosani","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Patente, T.A., Pinho, M.P., Oliveira, A.A., Evangelista, G.C.M., Bergami-Santos, P.C., and Barbuto, J.A.M. (2019). Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.03176"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e2219439120","DOI":"10.1073\/pnas.2219439120","article-title":"Mouse Models of Human Multiple Myeloma Subgroups","volume":"120","author":"Winkler","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Cordeiro, S., Oliveira, B.B., Valente, R., Ferreira, D., Luz, A., Baptista, P.V., and Fernandes, A.R. (2024). Breaking the Mold: 3D Cell Cultures Reshaping the Future of Cancer Research. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1507388"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Abuwatfa, W.H., Pitt, W.G., and Husseini, G.A. (2024). Scaffold-Based 3D Cell Culture Models in Cancer Research. J. Biomed. Sci., 31.","DOI":"10.1186\/s12929-024-00994-y"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1021\/acsbiomaterials.9b01731","article-title":"Signaling Molecule-Immobilized Porous Particles with a Leaf-Stacked Structure as a Bioactive Filler System","volume":"6","author":"Kim","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ashok, A., Choudhury, D., Fang, Y., and Hunziker, W. (2020). Towards Manufacturing of Human Organoids. Biotechnol. Adv., 39.","DOI":"10.1016\/j.biotechadv.2019.107460"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"1Belloni, D., Ferrarini, M., Ferrero, E., Guzzeloni, V., Barbaglio, F., Ghia, P., and Scielzo, C. (2022). Protocol for Generation of 3D Bone Marrow Surrogate Microenvironments in a Rotary Cell Culture System. STAR Protoc., 3, 101601.","DOI":"10.1016\/j.xpro.2022.101601"},{"key":"ref_35","first-page":"3015","article-title":"Deconstructing the Third Dimension\u2014How 3D Culture Microenvironments Alter Cellular Cues","volume":"125","author":"Baker","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molonc.2007.02.004","article-title":"The Morphologies of Breast Cancer Cell Lines in Three-dimensional Assays Correlate with Their Profiles of Gene Expression","volume":"1","author":"Kenny","year":"2007","journal-title":"Mol. Oncol."},{"key":"ref_37","first-page":"955","article-title":"Assessment of the culture requirements for optimal in vitro growth and survival of multiple myeloma cells","volume":"30","author":"Zlei","year":"2006","journal-title":"Leuk. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/1087057113478168","article-title":"A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells","volume":"18","author":"Misund","year":"2013","journal-title":"SLAS Discov. Adv. Sci. Drug Discov."},{"key":"ref_39","unstructured":"Ndubuisi, C., Dang, T., Staskiewicz, A., and Wang, X. (2024). Development of Cell Culture Models for Multiple Myeloma Drug Discovery: Comparison of Traditional 2D, Transwell 2D and 3D-Bioprinted Models. [Ph.D. Thesis]."},{"key":"ref_40","first-page":"830","article-title":"Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically","volume":"198","author":"Giliberto","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1073\/pnas.1010396108","article-title":"Contractility of the Cell Rear Drives Invasion of Breast Tumor Cells in 3D Matrigel","volume":"108","author":"Poincloux","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10616-017-0139-7","article-title":"Comparative Studies of Cellular Viability Levels on 2D and 3D in Vitro Culture Matrices","volume":"70","author":"Gargotti","year":"2018","journal-title":"Cytotechnology"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Rabionet, M., Yeste, M., Puig, T., and Ciurana, J. (2017). Electrospinning PCL Scaffolds Manufacture for Three-Dimensional Breast Cancer Cell Culture. Polymers, 9.","DOI":"10.3390\/polym9080328"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., and Tesei, A. (2016). 3D Tumor Spheroid Models for in Vitro Therapeutic Screening: A Systematic Approach to Enhance the Biological Relevance of Data Obtained. Sci. Rep., 6.","DOI":"10.1038\/srep19103"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3892\/or.2015.3767","article-title":"Comparison of 2D- and 3D-Culture Models as Drug-Testing Platforms in Breast Cancer","volume":"33","author":"Imamura","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"900","DOI":"10.7150\/jca.14506","article-title":"P53 Is Involved in a Three-Dimensional Architecture-Mediated Decrease in Chemosensitivity in Colon Cancer","volume":"7","author":"He","year":"2016","journal-title":"J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4041\/kjod.2014.44.6.320","article-title":"Compressive force regulates ephrinB2 and EphB4 in osteoblasts and osteoclasts contributing to alveolar bone resorption during experimental tooth movement","volume":"44","author":"Hou","year":"2014","journal-title":"Korean J. Orthod."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhang, W., Huang, G., and Xu, F. (2020). Engineering Biomaterials and Approaches for Mechanical Stretching of Cells in Three Dimensions. Front. Bioeng. Biotechnol., 8.","DOI":"10.3389\/fbioe.2020.589590"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00109-013-1020-6","article-title":"Exosomes in tumor microenvironment influence cancer progression and metastasis","volume":"91","author":"Kahlert","year":"2013","journal-title":"J. Mol. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-3495(72)86085-5","article-title":"Red Blood Cell Damage by Shear Stress","volume":"12","author":"Leverett","year":"1972","journal-title":"Biophys. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1083\/jcb.77.3.685","article-title":"Morphometric analysis of the translocation of lumenal membrane between cytoplasm and cell surface of transitional epithelial cells during the expansion-contraction cycles of mammalian urinary bladder","volume":"77","author":"Minsky","year":"1978","journal-title":"J. Cell Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/ten.tec.2023.0374","article-title":"Liquid Overlay and Collagen-Based Three-Dimensional Models for In Vitro Investigation of Multiple Myeloma","volume":"30","author":"Ilic","year":"2024","journal-title":"Tissue Eng. Part C Methods"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Hinsenkamp, A., Kun, K., Gajnut, F., Majer, A., Lacza, Z., and Horny\u00e1k, I. (2021). Cell Attachment Capacity and Compounds of Fibrin Membranes Isolated from Fresh Frozen Plasma and Cryoprecipitate. Membranes, 11.","DOI":"10.3390\/membranes11100783"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Pal, A., Tripathi, K., Pathak, C., and Vernon, B.L. (2019). Plasma-Based Fast-Gelling Biohybrid Gels for Biomedical Applications. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-47366-3"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Martini, S., Drzeniek, N.M., Stark, R., Kollert, M.R., Du, W., Reinke, S., Ort, M., Hardt, S., Kotko, I., and Kath, J. (2024). Long-Term in Vitro Maintenance of Plasma Cells in a Hydrogel-Enclosed Human Bone Marrow Microphysiological 3D Model System. Biofabrication, 16.","DOI":"10.1088\/1758-5090\/ad5dfe"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.actbio.2015.06.026","article-title":"Enzyme-Mediated Hyaluronic Acid\u2013Tyramine Hydrogels for the Propagation of Human Embryonic Stem Cells in 3D","volume":"24","author":"Xu","year":"2015","journal-title":"Acta Biomater."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/cimb43010026","article-title":"Three-Dimensional Reconstructed Bone Marrow Matrix Culture Improves the Viability of Primary Myeloma Cells In-Vitro via a STAT3-Dependent Mechanism","volume":"43","author":"Huang","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/\u03b2-Catenin Signaling: Components, Mechanisms, and Diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-Catenin Signaling, Disease, and Emerging Therapeutic Modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt Signaling in Cancer","volume":"36","author":"Zhan","year":"2017","journal-title":"Oncogene"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","article-title":"Targeting the Wnt\/Beta-Catenin Pathway in Cancer: Update on Effectors and Inhibitors","volume":"62","author":"Krishnamurthy","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41375-019-0486-9","article-title":"The WNT Receptor ROR2 Drives the Interaction of Multiple Myeloma Cells with the Microenvironment through AKT Activation","volume":"34","author":"Frenquelli","year":"2020","journal-title":"Leukemia"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Boulogeorgou, K., Papaioannou, M., Chatzileontiadou, S., Georgiou, E., Fola, A., Tzorakoleftheraki, S.-E., Hatjiharissi, E., and Koletsa, T. (2025). Unveiling Extramedullary Myeloma Immune Microenvironment: A Systematic Review. Cancers, 17.","DOI":"10.3390\/cancers17071081"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Huang, Y.-H., Molavi, O., Alshareef, A., Haque, M., Wang, Q., Chu, M.P., Venner, C.P., Sandhu, I., Peters, A.C., and Lavasanifar, A. (2018). Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model. Cancers, 10.","DOI":"10.20944\/preprints201803.0151.v2"},{"key":"ref_65","first-page":"321","article-title":"A High-Throughput, Three-Dimensional Multiple Myeloma Model Recapitulating Tumor-Stroma Interactions for CAR-Immune Cell-Mediated Cytotoxicity Assay","volume":"14","author":"Luanpitpong","year":"2025","journal-title":"Immunotargets Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.163.3.1274","article-title":"Activated Human T Cells Release Bioactive Fas Ligand and APO2 Ligand in Microvesicles","volume":"163","author":"Anel","year":"1999","journal-title":"J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature03337","article-title":"CD4+ T-Cell Help Controls CD8+ T-Cell Memory via TRAIL-Mediated Activation-Induced Cell Death","volume":"434","author":"Janssen","year":"2005","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/jcp.20512","article-title":"Involvement of TRAIL\/TRAIL-receptors in Human Intestinal Cell Differentiation","volume":"206","author":"Rimondi","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1182\/blood-2004-04-1294","article-title":"Activated Human NK and CD8+ T Cells Express Both TNF-Related Apoptosis-Inducing Ligand (TRAIL) and TRAIL Receptors but Are Resistant to TRAIL-Mediated Cytotoxicity","volume":"104","author":"Mirandola","year":"2004","journal-title":"Blood"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.neo.7900270","article-title":"Defining Characteristics of Types I and II Apoptotic Cells in Response to TRAIL","volume":"4","year":"2002","journal-title":"Neoplasia"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2478\/v10042-008-0027-2","article-title":"The Release of Soluble Forms of TRAIL and DR5 by Neutrophils of Oral Cavity Cancer Patients","volume":"46","author":"Jablonska","year":"2008","journal-title":"Folia Histochem. Cytobiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4236\/jct.2012.326120","article-title":"sTRAIL serum levels and TRAIL 1595 Genotypes: Associations with progress and prognosis of colorectal carcinoma","volume":"3","author":"Ozkan","year":"2012","journal-title":"J. Cancer Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5114\/aoms.2015.53144","article-title":"Assessment of Concentrations of sTRAIL Ligand and Its Receptors sTRAIL-R1 and sTRAIL-R2\u2014Markers Monitoring the Course of the Extrinsic Pathway of Apoptosis Induction: Potential Application in Ovarian Cancer Diagnostics","volume":"3","author":"Sikora","year":"2017","journal-title":"Aoms"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Pimentel, J.M., Zhou, J.-Y., and Wu, G.S. (2023). The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer. Cancers, 15.","DOI":"10.3390\/cancers15102752"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ygyno.2007.05.035","article-title":"Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and Its Therapeutic Potential in Breast and Gynecologic Cancers","volume":"106","author":"Kendrick","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple Myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/sj.leu.2404360","article-title":"A Microelectronic DNA Chip Detects the V617F JAK-2 Mutation in Myeloproliferative Disorders","volume":"20","author":"Moretti","year":"2006","journal-title":"Leukemia"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Pinto, V., Bergantim, R., Caires, H.R., Seca, H., Guimar\u00e3es, J.E., and Vasconcelos, M.H. (2020). Multiple Myeloma: Available Therapies and Causes of Drug Resistance. Cancers, 12.","DOI":"10.3390\/cancers12020407"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/14656566.2018.1441287","article-title":"Proteasome Inhibitors for the Treatment of Multiple Myeloma","volume":"19","author":"Scalzulli","year":"2018","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_80","first-page":"2615","article-title":"Proteasome inhibitors: A novel class of potent and effective antitumor agents","volume":"59","author":"Adams","year":"1999","journal-title":"Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Schmitt, S.M., Deshmukh, R.R., and Dou, Q.P. (2014). Proteasome Inhibitors and Lessons Learned from Their Mechanisms of Action and resistance in Human Cancer. Resistance to Proteasome Inhibitors in Cancer: Molecular Mechanisms and Strategies to Overcome Resistance, Springer International Publishing.","DOI":"10.1007\/978-3-319-06752-0_1"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","article-title":"Multi-Drug Resistance in Cancer Chemotherapeutics: Mechanisms and Lab Approaches","volume":"347","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Yang, W.-C., and Lin, S.-F. (2015). Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma. BioMed Res. Int., 2015.","DOI":"10.1155\/2015\/341430"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0305-7372(03)00079-3","article-title":"Rationale for the Treatment of Solid Tumors with the Proteasome Inhibitor Bortezomib","volume":"29","author":"Cusack","year":"2003","journal-title":"Cancer Treat. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1158\/1078-0432.CCR-19-0959","article-title":"Correction: Dual Inhibition of Canonical and Noncanonical NF-\u03baB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma","volume":"25","author":"Fabre","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1541-7786.MCR-08-0108","article-title":"Bortezomib-Resistant Nuclear Factor-\u03baB Activity in Multiple Myeloma Cells","volume":"6","author":"Markovina","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc2714","article-title":"Environment-Mediated Drug Resistance: A Major Contributor to Minimal Residual Disease","volume":"9","author":"Meads","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Yetisgin, A.A., Cetinel, S., Zuvin, M., Kosar, A., and Kutlu, O. (2020). Therapeutic Nanoparticles and Their Targeted Delivery Applications. Molecules, 25.","DOI":"10.3390\/molecules25092193"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Iannazzo, D., Ettari, R., Giofr\u00e8, S., Eid, A.H., and Bitto, A. (2020). Recent Advances in Nanotherapeutics for Multiple Myeloma. Cancers, 12.","DOI":"10.3390\/cancers12113144"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jconrel.2017.11.045","article-title":"Enhancing Proteasome-Inhibitory Activity and Specificity of Bortezomib by CD38 Targeted Nanoparticles in Multiple Myeloma","volume":"270","author":"Luderer","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Nigro, A., Frattaruolo, L., Fava, M., De Napoli, I., Greco, M., Comand\u00e8, A., De Santo, M., Pellegrino, M., Ricci, E., and Giordano, F. (2020). Bortezomib-Loaded Mesoporous Silica Nanoparticles Selectively Alter Metabolism and Induce Death in Multiple Myeloma Cells. Cancers, 12.","DOI":"10.3390\/cancers12092709"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Habanjar, O., Diab-Assaf, M., Caldefie-Chezet, F., and Delort, L. (2021). 3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212200"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13402-024-00960-8","article-title":"A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine","volume":"48","author":"Kalla","year":"2025","journal-title":"Cell Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Jensen, C., and Teng, Y. (2020). Is It Time to Start Transitioning From 2D to 3D Cell Culture?. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.00033"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","article-title":"Progress and Potential in Organoid Research","volume":"19","author":"Rossi","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-019-0829-z","article-title":"Applications of Patient-Derived Tumor Xenograft Models and Tumor Organoids","volume":"13","author":"Yoshida","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41556-019-0407-1","article-title":"CD9 Identifies Pancreatic Cancer Stem Cells and Modulates Glutamine Metabolism to Fuel Tumour Growth","volume":"21","author":"Wang","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1126\/science.25.649.912","article-title":"A New Method by Which Sponges May Be Artificially Reared","volume":"25","author":"Wilson","year":"1907","journal-title":"Science"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1247125","DOI":"10.1126\/science.1247125","article-title":"Organogenesis in a Dish: Modeling Development and Disease Using Organoid Technologies","volume":"345","author":"Lancaster","year":"2014","journal-title":"Science"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-018-0662-9","article-title":"Organoid Technology and Applications in Cancer Research","volume":"11","author":"Xu","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-pathmechdis-012419-032611","article-title":"Human Organoids: Tools for Understanding Biology and Treating Diseases","volume":"15","author":"Schutgens","year":"2020","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Holokai, L., Chakrabarti, J., Lundy, J., Croagh, D., Adhikary, P., Richards, S.S., Woodson, C., Steele, N., Kuester, R., and Scott, A. (2020). Murine- and Human-Derived Autologous Organoid\/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma. Cancers, 12.","DOI":"10.3390\/cancers12123816"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12935-024-03272-x","article-title":"Application status and optimization suggestions of tumor organoids and CAR-T cell co-culture models","volume":"24","author":"Ning","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nm.4441","article-title":"CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature14415","article-title":"Sequential cancer mutations in cultured human intestinal stem cells","volume":"521","author":"Drost","year":"2015","journal-title":"Nature"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.stem.2017.12.009","article-title":"Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression","volume":"22","author":"Seino","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.stem.2016.04.003","article-title":"A Colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis","volume":"18","author":"Fujii","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"101250","DOI":"10.1016\/j.omtm.2024.101250","article-title":"CAR-T cell manufacturing landscape-Lessons from the past decade and considerations for early clinical development","volume":"32","author":"Dias","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6229\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:00:31Z","timestamp":1760032831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":111,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26136229"],"URL":"https:\/\/doi.org\/10.3390\/ijms26136229","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}